Figure 8.The functional pathways and gene alteration of FAM72A-D in LUAD. (A) Several pathways were enriched in FAM72A-D related LUAD, including the proliferation, EGFR signaling, undifferentiated cancer, lung cancer poor survival and cell cycle; (B, C) Genetic alteration in FAM72A-D and its association with OS of LUAD patients.
